Ptc Therapeutics reported $-33710000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amgen AMGN:US USD 3.5B 62M
Biogen BIIB:US USD 992.8M 82.9M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Bluebird Bio BLUE:US USD -85093000 14.32M
Cytokinetics CYTK:US USD -107033000 97.57M
Daiichi Sankyo 4568:JP JPY 76.31B 27.06B
Esperion Therapeutics ESPR:US USD -41518000 10.71M
Gilead Sciences GILD:US USD 3.28B 731M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Ironwood Pharmaceuticals IRWD:US USD 68.84M 12.82M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Novartis NOVN:VX USD 4.69B 34M
Pfizer PFE:US USD 10.52B 2.78B
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Roche Holding ROG:VX 13.44B 2.56B
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Tg Therapeutics TGTX:US USD -34887000 3.98M
Ultragenyx Pharmaceutical RARE:US USD -220372000 83.26M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
Xencor XNCR:US USD -36110000 10.33M
YTE INCY:US USD 134.94M 141.85M